L'osteoporosi i els bifosfonats
Abstract
Essencial is an initiative that identifies low-value clinical practices and promotes recommendations to avoid them. This recommendation highlights that in menopausal women on bisphosphonate treatment who are at low risk of fracture, it is recommended to evaluate after 3 to 5 years the need to maintain bisphosphonate treatment.
Keywords
Osteoporosis; Bisphosphonates; Menopausal womenBibliographic citation
L'osteoporosi i els bifosfonats. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya; 2022.
Audience
Ciutadania
This item appears in following collections
The following license files are associated with this item:




